SCHEMBL386177

SCHEMBL386177

CCCCCCCCCCCC1(O)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1070145 1.00
SCHEMBL4777211 1.00
SCHEMBL9637160 1.00
SCHEMBL1903763 1.00
SCHEMBL7673861 1.00
SCHEMBL3804023 0.89 LMNA (0.42)
SCHEMBL18423851 0.86 SIRT2 (0.37)
SCHEMBL5698597 0.84 SIRT2 (0.36)
SCHEMBL21353932 0.83 SIRT2 (0.35)
SCHEMBL9701164 0.82 CPT2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1969814-B Nasal administered preparation of melatonin INST PHARM & TOXICOLOGY AMMS 2010-05-26 CN claimed
CN-1969814-A Nasal administered preparation of melatonin POISON MED INST PLA MED ACAD (CN) 2007-05-30 CN claimed
US-5077199-A Comprising glucose oxidase free from catalase and nonionic surfactant stabilizer A. MENARINI S.A.S. (IT) 1991-12-31 US claimed
JP-54150379-A None JP disclosed
US-20240207411-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS SEAPORT THERAPEUTICS, INC. 2024-06-27 US disclosed
US-11975073-B2 Lipid prodrugs of neurosteroids PURETECH LYT, INC. (US) 2024-05-07 US disclosed
US-11938137-B2 Lipid prodrugs of mycophenolic acid and uses thereof PURETECH LYT, INC. (US) 2024-03-26 US disclosed
US-20240066436-A1 BIOBASED DEFOAMER COMPOSITIONS AND METHODS OF PREPARATION THEREOF KRATON CHEMICAL, LLC (US) 2024-02-29 US disclosed
US-20240050573-A1 LYMPH DIRECTING PRODRUGS MONASH UNIVERSITY (AU) 2024-02-15 US disclosed
US-11883497-B2 Lymphatic system-directing lipid prodrugs PURETECH LYT, INC. (US) 2024-01-30 US disclosed
EP-4306524-A2 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS PureTech LYT, Inc. (US) 2024-01-17 EP disclosed
US-20070180895-A1 Hair coloring system and test device capable of being used in such a system L'OREAL S.A. (FR) 2007-08-09 US disclosed
EP-1648262-A1 HAIR COLORING SYSTEM AND TEST DEVICE CAPABLE OF BEING USED IN SUCH A SYSTEM L'OREAL (FR) 2006-04-26 EP disclosed
WO-2005013759-A1 HAIR COLORING SYSTEM AND TEST DEVICE CAPABLE OF BEING USED IN SUCH A SYSTEM L'OREAL (FR) 2005-02-17 WO disclosed
EP-0252690-B1 ANTISTATIC PLASTICISERS BP Chemicals Limited (GB) 1992-08-12 EP disclosed
EP-0422599-A1 Antigen-sensitized bead and use thereof Takeda Chemical Industries, Ltd. (JP) 1991-04-17 EP disclosed
EP-0252690-A2 Antistatic plasticisers BP Chemicals Limited (GB) 1988-01-13 EP disclosed
US-4707293-A Detergent composition CRINOS INTERNATIONAL (CH) 1987-11-17 US disclosed
JP-S54150379-A NOVEL SNOW MELTING AGENT COMPOSITION NIPPON CARBIDE IND CO LTD 1979-11-26 JP disclosed
US-3978204-A PAPER TOWELING SUPPORT L'OREAL (FR) 1976-08-31 US disclosed